Haemophilia care in China: achievements of a decade of World Federation of Hemophilia treatment centre twinning activities.
about
Comprehensive analysis of phenotypes and genetics in 21 Chinese families with haemophilia B: characterization of five novel mutations.Mild hemophilia A.Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China.Recombinant factor VIII in the management of hemophilia A: current use and future promise.Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements.Joint protection in haemophilia.Haemophilia prophylaxis: how can we justify the costs?Meeting the challenges of haemophilia care and patient support in China and Brazil.Hemophilia care in China: review of care for 417 hemophilia patients from 11 treatment centers in Shanxi Province.Emerging drugs for the treatment of hemophilia A and B.'Train-the-Trainer': an effective and successful model to accelerate training and improve physiotherapy services for persons with haemophilia in China.The demographics, treatment characteristics and quality of life of adult people with haemophilia in China - results from the HERO study.Trends in the epidemiology, diagnosed age and mortality rate of haemophiliacs in Taiwan: a population-based study, 1997-2009.Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population.A study of reported factor IX use around the world.Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre.The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE Study.Joint disease status of severe and moderate haemophilia patients at the Beijing Children's Hospital: early onset and rapid increasing severity of arthropathy in 90% of patients by 6 years of age.Validation of the Chinese version of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (the CHO-KLAT).Efficacy of standard prophylaxis versus on-demand treatment with bayer's sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with severe hemophilia A.The natural history of mild haemophilia: a 30-year single centre experience.The benefit of low dose prophylaxis in the treatment of hemophilia: a focus on China.Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China.Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B.Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China.
P2860
Q30367118-CB5344A1-855E-413A-A15B-0E81FFB0D68DQ34614695-C7859A02-8998-4035-9A40-51F1FB3A9671Q36402938-CC462BCD-34BC-4A53-B36A-52410B4653A3Q37230340-4F4351B3-EDA8-4932-B0C8-CC8D95AD25CEQ37894820-E53CCA56-F95A-4B2F-B69F-2E666ADE7A40Q37912258-BB87030C-AE0E-4D11-B180-E6CB1B1BB94FQ38002994-704D86D1-BABD-4E70-82EC-E87D01910AF6Q38023505-21417B88-5843-4346-BDD3-AB3744B7EBB7Q38463150-BA9E663F-79A1-4964-B33E-F5C62BF93FC7Q38933707-CD2630A5-5373-47A6-9A2A-5D25BADB176AQ39312115-711845F7-D1DD-46CB-96ED-C7ECCAAB618AQ40593079-BB696A45-6118-4A2E-ACF9-A9B6A92E3F39Q42240547-A91E478B-40AB-4B8D-AAE8-D8284422032AQ43938600-69A975FD-1110-4F1A-8ED7-9554CEF6E98CQ44859791-A70772C5-9FBB-4123-937C-0F82ACE75C54Q45857838-FD5A80A2-9488-4E96-B4DD-260A599D83BCQ45862594-EC8BADE4-2D2F-49B3-B875-C6A233B253CEQ45862980-B1ED6CC2-704C-4222-A121-1685B05D61E3Q45869008-1FD7A085-020B-4364-A478-C8CEC2620F3EQ45869935-0186FF25-0881-4C52-91C6-A2DA2ACFA234Q45871908-C4C5D951-EFE6-4180-AD48-F051DC81B775Q45872720-CF7AAAE8-8FA7-4B5B-B06A-30401DAF545DQ45874599-981EC839-53A4-4464-BDAC-B8B00372C46EQ45880341-C4C740F2-80CD-4425-92DE-95FAF82BA0ADQ45883686-19F5984C-1F7D-4775-8F21-A7A8FE78D4CF
P2860
Haemophilia care in China: achievements of a decade of World Federation of Hemophilia treatment centre twinning activities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Haemophilia care in China: ach ...... nt centre twinning activities.
@en
Haemophilia care in China: ach ...... nt centre twinning activities.
@nl
type
label
Haemophilia care in China: ach ...... nt centre twinning activities.
@en
Haemophilia care in China: ach ...... nt centre twinning activities.
@nl
prefLabel
Haemophilia care in China: ach ...... nt centre twinning activities.
@en
Haemophilia care in China: ach ...... nt centre twinning activities.
@nl
P1433
P1476
Haemophilia care in China: ach ...... nt centre twinning activities.
@en
P2093
P304
P356
10.1111/J.1365-2516.2008.01821.X
P577
2008-07-15T00:00:00Z